Flemming Ørnskov
Flemming Ørnskov, M.D., MPH (born 1957/58) is a Danish businessman. He has been the chief executive officer (CEO) of Galderma since October 2019. 

He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel. He previously worked for Bayer, Bausch & Lomb and Novartis.

He is also a director at Waters Corporation. 

Ørnskov received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University.
Q581008
Galderma
ORG
Q905049
Shire plc
ORG
Q466496
FTSE 100
MEDIA
Q4764240
Angus Russel
PER
Q152051
Bayer
Concept
Q507154
Novartis
ORG
Q1322011
Waters Corporation
ORG
Q186285
University of Copenhagen
ORG
Q1136829
INSEAD
ORG
Q203196
Master of Public Health
Concept
Q13371
Harvard University
ORG
Q16733839
Flemming Ørnskov
PER
1957-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
1957
DATE
2019-10-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
October 2019
DATE
2013-04-30T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
30 April 2013
DATE
+58^^http://www.w3.org/2001/XMLSchema#decimal
58
NUMBER
employer
employer
part of
chief executive officer